Bimekizumab speed of response in patients with moderate to severe plaque psoriasis: Results from four phase 3/3b trials (BE VIVID, BE READY, BE SURE, and BE RADIANT). (2022). SKIN The Journal of Cutaneous Medicine, 6(6), s69. https://doi.org/10.25251/skin.6.supp.69